Meet with Legend Capital

China’s biotech sector is producing a new generation of companies with globally competitive science, differentiated pipelines, and ambitions that extend well beyond the domestic market. As these companies look to access international capital, partners, talent, and markets, Singapore is increasingly emerging as a compelling base for global expansion. Its strategic location at the heart of Asia, globally aligned regulatory framework, and deep ecosystem spanning research, clinical development, biomanufacturing, investment, and commercialization make it a natural launchpad into Asia Pacific and the rest of the world.    Join JLABS Singapore for an exclusive session with Legend Capital exploring trends shaping China’s biotech sector, the firm’s healthcare investment approach, and its investments in Singapore. Drawing on investor and portfolio-company perspectives, the session will examine why companies choose Singapore, how the right venture-capital partnership can support their growth, and the opportunities and challenges involved in R&D, manufacturing, commercialization, and international expansion.

Due to our compliance policy, advance registration is required for all guests. Registrations are non-transferable, and walk-ins will not be permitted. This event is intended for members of the life sciences community. The organizer reserves the right to decline or cancel registrations from individuals outside the intended audience or whose participation does not align with the purpose of the event. 

Note: Photography and videography will be captured during this event. Through your participation, you are granting Johnson & Johnson consent to utilize these images and videos for promotional purposes, which may include social media, website and publication. If you do not wish to be photographed, kindly inform the photographer at the event.